Related Experiment Video
Updated: Nov 21, 2025

04:17
DNA Virus Detection System Based on RPA-CRISPR/Cas12a-SPM and Deep Learning
Published on: May 10, 2024
1.2K
Deep Learning in the Quest for Compound Nomination for Fighting COVID-19
Maria Mernea1, Eliza C Martin2, Andrei-José Petrescu2
1Department of Anatomy, Animal Physiology and Biophysics, Faculty of Biology, University of Bucharest, Splaiul Independenţei 91-95, 050095 Bucharest, Romania.
Current Medicinal Chemistry
|January 14, 2021
Summary
Deep learning models rapidly advanced COVID-19 research, aiding outbreak assessment, diagnostics, and drug discovery. Advanced machine learning techniques show promise for combating the pandemic and alleviating symptoms.
Area of Science:
- Biomedical research
- Computational biology
- Epidemiology
Background:
- The COVID-19 pandemic spurred rapid advancements in biomedical research and clinical response.
- Multidimensional data generated during the pandemic provided a rich framework for computational analysis.
Purpose of the Study:
- To review the application of deep learning and machine learning in COVID-19 research.
- To focus on research concerning COVID-19 targets, drug discovery, and symptom management.
Main Methods:
- Utilizing deep learning for data analysis and model building.
- Employing machine learning techniques for prediction-validation workflows.
- Reviewing computational strategies for drug identification and repurposing.
Main Results:
- Deep learning models have been instrumental in assessing outbreak spread, taxonomy, and population susceptibility.
- Significant progress has been made in diagnostics and drug discovery/repurposing within months.
- Computational approaches are yielding results in identifying therapeutic strategies.
Conclusions:
- Advanced machine learning techniques are crucial for understanding and combating the COVID-19 pandemic.
- Continued application of these methods is expected to yield further breakthroughs.
- Research is focusing on therapeutic targets and drug development to manage COVID-19.
Keywords:
SARS-CoV-2deep learningdrug designdrug repurposing.drug-target interactionsvirtual screening
